Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
5
×
life sciences
national blog main
5
×
san francisco blog main
biotech
boston blog main
national top stories
new york blog main
boston top stories
cancer immunotherapy
deals
new york top stories
san francisco top stories
cancer
chronic kidney disease
clinical trials
food and drug administration
investing
medical device
national
raleigh-durham blog main
startups
acute myeloid leukemia
akili interactive labs
alx oncology
autoimmune diseases
berkeley lights
biotech ipos
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
bruce leuchter
cancer drugs
cancer vaccine
cd47
center for medicare and medicaid services
click therapeutics
clickotine
companion diagnostic
What
momentum
5
×
therapeutics
companies
drug
gain
ipo
latest
life
medicine
new
raised
science
week
acquire
agreed
announced
arrival
backs
bets
big
billion
biotech
biotechs
broad
building
click
club
confidence
continued
crop
days
deal
developer
didn’t
digital
disease
established
example
exceeded
field
Language
unset
Current search:
momentum
×
fda
×
" national blog main "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed